Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$382M |
| 2 |
Pfizer
PFE
|
+$266M |
| 3 |
Electronic Arts
EA
|
+$240M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Colgate-Palmolive
CL
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$358M |
| 2 |
Comcast
CMCSA
|
+$263M |
| 3 |
Meta Platforms (Facebook)
META
|
+$258M |
| 4 |
AET
Aetna Inc
AET
|
+$257M |
| 5 |
Tesla
TSLA
|
+$189M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.14% |
| 2 | Technology | 13.55% |
| 3 | Financials | 11.85% |
| 4 | Consumer Staples | 10.18% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSRA
776
DELISTED
CSRA Inc.
CSRA
| $22.6M | 0.03% |
710,351
+200,251
| +39% | +$6M |
|
777
Capri Holdings
CPRI
$1.77B
| $22.5M | 0.03% |
621,000
+303,800
| +96% | +$11M |
|
|
PBCT
778
DELISTED
People's United Financial Inc
PBCT
| $22.5M | 0.03% |
1,274,586
+517,377
| +68% | +$8.99M |
|
779
Insperity
NSP
$1.85B
| $22.5M | 0.03% |
633,266
+313,098
| +98% | +$12.7M |
|
780
First Interstate BancSystem
FIBK
$3.7B
| $22.5M | 0.03% |
603,919
+239,219
| +66% | +$8.98M |
|
781
Visteon
VC
$2.77B
| $22.4M | 0.03% |
219,309
+77,009
| +54% | +$7.61M |
|
|
NAVG
782
DELISTED
Navigators Group Inc
NAVG
| $22.4M | 0.03% |
407,492
+70,200
| +21% | +$3.73M |
|
783
Enanta Pharmaceuticals
ENTA
$372M
| $22.3M | 0.03% |
620,500
+52,807
| +9% | +$1.69M |
|
784
ITT
ITT
$17.5B
| $22.3M | 0.03% |
555,500
+302,300
| +119% | +$12.1M |
|
785
Alarm.com
ALRM
$2.56B
| $22.3M | 0.03% |
593,000
+226,000
| +62% | +$7.57M |
|
|
ZVO
786
DELISTED
Zovio Inc. Common Stock
ZVO
| $22.3M | 0.03% |
1,507,558
+198,900
| +15% | +$2.67M |
|
|
GNCMA
787
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $22.2M | 0.03% |
606,400
-17,100
| -3% | -$618K |
|
788
Elbit Systems
ESLT
$38.4B
| $22.2M | 0.03% |
179,535
-19,700
| -10% | -$2.37M |
|
|
BBT
789
Beacon Financial Corp
BBT
$2.53B
| $22.2M | 0.03% |
631,043
+122,886
| +24% | +$4.42M |
|
790
Federal Realty Investment Trust
FRT
$10.9B
| $22.2M | 0.03% |
175,300
+119,300
| +213% | +$15.4M |
|
791
Sociedad Química y Minera de Chile
SQM
$19.6B
| $22.2M | 0.03% |
670,900
-114,600
| -15% | -$4.03M |
|
792
ICICI Bank
IBN
$106B
| $22.1M | 0.03% |
+2,464,750
| New | +$20.8M |
|
793
Crown Holdings
CCK
$12.8B
| $22.1M | 0.03% |
370,500
-496,400
| -57% | -$28M |
|
794
Mativ Holdings
MATV
$448M
| $22.1M | 0.03% |
593,400
+28,100
| +5% | +$1.11M |
|
795
Otter Tail
OTTR
$3.88B
| $22M | 0.03% |
555,510
+127,110
| +30% | +$5M |
|
796
Washington Trust Bancorp
WASH
$732M
| $22M | 0.03% |
426,168
+1,800
| +0.4% | +$89.6K |
|
|
SYKE
797
DELISTED
SYKES Enterprises Inc
SYKE
| $21.9M | 0.03% |
653,673
+32,100
| +5% | +$1.02M |
|
798
CDW
CDW
$17.1B
| $21.9M | 0.03% |
349,498
-239,100
| -41% | -$14.3M |
|
|
KBAL
799
DELISTED
Kimball International
KBAL
| $21.8M | 0.03% |
1,308,991
+233,800
| +22% | +$4.05M |
|
800
Citizens Financial Group
CFG
$30.4B
| $21.8M | 0.03% |
611,600
-840,200
| -58% | -$29.8M |
|
Similar funds
Renaissance Technologies's Q2 2017 Portfolio in Review
As of Q2 2017, Renaissance Technologies held 3,586 positions worth $78.4B, up 9.5% from $71.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Renaissance Technologies deployed $4.59B of net new capital in Q2 2017, opening 398 new positions and adding to 1,648 existing holdings. Its largest new stake was Pfizer: 8,421,609 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Comcast, an estimated $263M trimmed.
- Renaissance Technologies's largest Q2 2017 buy was Pfizer: 8,421,609 shares worth $268M.
- Renaissance Technologies added most to Bristol-Myers Squibb in Q2 2017, an estimated $382M increase.
- Renaissance Technologies's biggest Q2 2017 reduction was Comcast, cutting an estimated $263M.
- Renaissance Technologies fully exited Booking.com in Q2 2017, selling an estimated $358M.
- Renaissance Technologies's ten largest holdings make up 9% of its $78.4B portfolio in Q2 2017.
- Renaissance Technologies opened 398 new positions and closed 418 in Q2 2017.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $78.4B.
Based on Renaissance Technologies's 13F filing for Q2 2017, filed 11 Aug 2017.